U.S. flag

An official website of the United States government

NM_000067.3(CA2):c.275A>C (p.Gln92Pro) AND Osteopetrosis with renal tubular acidosis

Germline classification:
Likely pathogenic (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001250415.1

Allele description [Variation Report for NM_000067.3(CA2):c.275A>C (p.Gln92Pro)]

NM_000067.3(CA2):c.275A>C (p.Gln92Pro)

Gene:
CA2:carbonic anhydrase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8q21.2
Genomic location:
Preferred name:
NM_000067.3(CA2):c.275A>C (p.Gln92Pro)
HGVS:
  • NC_000008.11:g.85473735A>C
  • NG_007287.1:g.14719A>C
  • NM_000067.3:c.275A>CMANE SELECT
  • NM_001293675.2:c.49-589A>C
  • NP_000058.1:p.Gln92Pro
  • NC_000008.10:g.86385964A>C
  • p.Q92P
Protein change:
Q92P
Links:
dbSNP: rs1304160279
NCBI 1000 Genomes Browser:
rs1304160279
Molecular consequence:
  • NM_001293675.2:c.49-589A>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000067.3:c.275A>C - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
functionally_abnormal [Sequence Ontology: SO:0002218]
Observations:
1

Condition(s)

Name:
Osteopetrosis with renal tubular acidosis (OPTB3)
Synonyms:
Autosomal recessive osteopetrosis type 3; Guibaud Vainsel syndrome; Marble brain disease; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009818; MedGen: C0345407; Orphanet: 2785; OMIM: 259730

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001364072Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, SCV001364072.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
11not providednot providedclinical testing PubMed (1)

Description

The index patient has a homozygous missense mutation at position 275 on the cDNA level of the CA2 gene, which leads to the exchange of the amino acid glutamic acid to proline at position 92 on the protein level. The co-segregation analysis showed that the clinically affected brother carries the sequence variant also in a homozygous state and the healthy parents are each heterozygous carriers. Several prediction programs classify this amino acid exchange as pathogenic (PP3). The sequence variant is not listed in the databases ExAC and gnomAD (PM2). The above sequence variant has already been described in three patients with osteopetrosis and renal acidosis (MIM# 259739) in homozygous state (PP5) (Hu et al. 1997; Shah et al. 2004). According to the current state of knowledge, this is a probable pathogenic mutation (class IV).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Apr 23, 2022